Literature DB >> 2293572

Ascitic fluid polymorphonuclear cell count and serum to ascites albumin gradient in the diagnosis of bacterial peritonitis.

A Albillos1, V Cuervas-Mons, I Millán, T Cantón, J Montes, C Barrios, A Garrido, P Escartín.   

Abstract

The analysis of ascitic fluid has been complicated by several recently reported new tests. To simplify this assessment, we evaluated nine parameters prospectively and simultaneously in blood and ascitic fluid from 285 patients with ascites to determine which were the most reliable for immediate diagnosis of the etiology of the ascites and of its complications. Subjects were first divided into four groups: sterile cirrhotic ascites (n = 201), spontaneous bacterial peritonitis (n = 41), malignant ascites (n = 34), and miscellaneous ascites (n = 9). An ascitic fluid polymorphonuclear count greater than 500/microliters was the test with the greatest accuracy (96%) for the diagnosis of spontaneous bacterial peritonitis. Neither the most precise cutoff values for ascitic fluid pH (less than 7.32) and ascitic fluid lactate (greater than 32 mg/dl), nor their respective blood-ascitic fluid gradients (greater than 0.11 and less than -20 mg/dl) were more reliable indexes of spontaneous bacterial peritonitis, mainly due to the decreased ascitic fluid pH and increased ascitic fluid lactate observed in malignant ascites, tuberculous peritonitis, and pancreatic ascites. A blood-ascitic fluid albumin gradient less than 1.1 g/dl was the most accurate parameter for the diagnosis of malignant ascites (diagnostic efficacy, 93%). Therefore, the etiologic analysis of ascitic fluid might be simplified and the single practice of two tests, ascitic fluid polymorphonuclear cell count and blood-ascitic fluid albumin gradient, provides immediately useful information.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2293572     DOI: 10.1016/0016-5085(90)91301-l

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  17 in total

Review 1.  Dose adaptation of antineoplastic drugs in patients with liver disease.

Authors:  Lydia Tchambaz; Chantal Schlatter; Max Jakob; Anita Krähenbühl; Peter Wolf; Stephan Krähenbühl
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

2.  Guidelines on the management of ascites in cirrhosis.

Authors:  K P Moore; G P Aithal
Journal:  Gut       Date:  2006-10       Impact factor: 23.059

Review 3.  Ascites in Children.

Authors:  Ashish Bavdekar; Nitin Thakur
Journal:  Indian J Pediatr       Date:  2016-06-09       Impact factor: 1.967

4.  Discrimination between malignant and nonmalignant ascites using serum and ascitic fluid proteins in a multivariate analysis model.

Authors:  M G Alexandrakis; J A Moschandrea; S A Koulocheri; E Kouroumalis; G D Eliopoulos
Journal:  Dig Dis Sci       Date:  2000-03       Impact factor: 3.199

5.  Spontaneous bacterial peritonitis complicating malignancy-related ascites.

Authors:  D V Bac; S de Marie; M van Blankenstein
Journal:  Dig Dis Sci       Date:  1996-01       Impact factor: 3.199

Review 6.  Infectious complications of liver disease.

Authors:  P D King
Journal:  J Gen Intern Med       Date:  1993-06       Impact factor: 5.128

7.  Diagnosis and management of bacterial infections in decompensated cirrhosis.

Authors:  Maria Pleguezuelo; Jose Manuel Benitez; Juan Jurado; Jose Luis Montero; Manuel De la Mata
Journal:  World J Hepatol       Date:  2013-01-27

8.  Translocation of bacterial DNA from Gram-positive microorganisms is associated with a species-specific inflammatory response in serum and ascitic fluid of patients with cirrhosis.

Authors:  R Francés; J M González-Navajas; P Zapater; C Muñoz; R Caño; S Pascual; F Santana; D Márquez; M Pérez-Mateo; J Such
Journal:  Clin Exp Immunol       Date:  2007-09-05       Impact factor: 4.330

9.  Measurement of calprotectin in ascitic fluid to identify elevated polymorphonuclear cell count.

Authors:  Emanuel Burri; Felix Schulte; Jürgen Muser; Rémy Meier; Christoph Beglinger
Journal:  World J Gastroenterol       Date:  2013-04-07       Impact factor: 5.742

10.  Regulatory role of PI3K-protein kinase B on the release of interleukin-1β in peritoneal macrophages from the ascites of cirrhotic patients.

Authors:  A Tapia-Abellán; A J Ruiz-Alcaraz; G Antón; M Miras-López; R Francés; J Such; M Martínez-Esparza; P García-Peñarrubia
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.